
Was the Government’s DUP deal an act of bribery?
As we all know, the 2017 general election did not result in a majority Conservative government. As a result, Teresa May struck a deal with the Democratic Unionist Party (DUP)
As we all know, the 2017 general election did not result in a majority Conservative government. As a result, Teresa May struck a deal with the Democratic Unionist Party (DUP)
As announced previously, PowerHouse Energy Group PLC (LON:PHE), the company focused on ultra-high-temperature waste-to-energy and waste-to-hydrogen systems and the creator of Distributed Modular Gasification (DMG©), is to host two Open Days, with technology
ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today confirmed a further update on Lupuzor™ its lead programme for the potential breakthrough compound for Lupus, the life threatening
Haydale Graphene Industries Plc (LON:HAYD), the global advanced materials group, has today announced the first commercial sales of its products to Everpower Sheng Tie (Xiamen) Graphene Technology Co., Ltd. (“Everpower”). The
Strix Group PLC (LON:KETL), the global leader in the design, manufacture and supply of kettle safety controls and other components and devices, has announced that it has changed its registered
Mi-Pay Group PLC (LON:MPAY), a leading provider of digital transformation and mobile payment solutions to Tier 1 Mobile Network Operators and Mobile Virtual Network Operators, has today presented its unaudited
Gateley Holdings Plc (LON:GTLY) is the topic of conversation when Hardman & Co Analyst Steve Clapham joins DirectorsTalk. Steve explains why Gateley have become the first major UK law firm
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is pleased to confirm a further update on Lupuzor(TM) its lead programme for the potential breakthrough compound for Lupus, the
Widecells Group Plc (LON:WDC) CEO João Andrade & Vice President of WideAcademy Alan Greenberg talks to DirectorsTalk about the development of a bespoke stem cell focused educational platform to deliver
Mark Braund, Chief Executive Officer, commented on the new contract wins: “RedstoneConnect’s ability to deploy future-proof technology in a seamless and cost-efficient manner has been central in securing these high-profile contracts.